Search

everythinglearnresearchcommunity

for

Search:↓

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Biological therapy boosts the immune system to effectively fight melanoma.

Upadacitinib effectively treats pyoderma gangrenosum.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

3D imaging effectively tracks skin changes in vitiligo treatment.

BMS-470539 reduces skin fibrosis and inflammation.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.